Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132711) titled 'Study on the Efficacy of Ganagliflozin Proline Tablets in Subjects with Type 2 Diabetes Mellitus or Prediabetes Accompanied by Carotid Artery Plaque' on Sept. 17.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Afliated Hospital Zhejiang University School of Medicine
Condition:
type 2 diabetes or prediabetes accompanied by carotid atherosclerotic plaques
Intervention:
Experimental group:Ganagliflozin Proline Tablets plus lifestyle intervention
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Experimental group:3...